# FDA recall D-1425-2014

> **Hospira Inc.** · Class II · drug recall initiated 2014-06-06.

## Product

Heparin Sodium in 5% Dextrose Injection, Heparin, 25,000 USP Heparin Units/250 mL (100 USP Heparin Units/mL), 250 mL, Single-Dose Container, Hospira, Inc., Lake Forest, IL 60045 USA,  NDC 0409-7793-62

## Reason for recall

Lack of Assurance of Sterility: Confirmed consumer report of fluid leaking from primary container of bag.

## Distribution

Nationwide

## Key facts

- **Recall number:** D-1425-2014
- **Recalling firm:** Hospira Inc.
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2014-06-06
- **Report date:** 2014-07-16
- **Termination date:** 2015-04-03

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Lake Forest, IL, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-1425-2014

## Citation

> AI Analytics. FDA recall D-1425-2014. Retrieved 2026-06-02 from https://api.ai-analytics.org/recall/D-1425-2014. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*